Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05578664
Title Efficacy of PErioperative PEmbrolizumab Treatment in Patients With Resectable Metastases From Kidney Cancer (PE-PE)
Acronym PE-PE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Consorzio Oncotech
Age Groups: adult | senior
Covered Countries ITA

No variant requirements are available.